British tech company Skin Analytics has received regulatory approval for an AI skin cancer detection system that uses a ...

Odell Beckham Jr. (OBJ) and his dermatologist discuss his experience with seb derm, or seborrheic dermatitis, as the Wide ...

Roth MKM analyst Jason Wittes maintained a Buy rating on Journey Medical Corp (DERM – Research Report) today and set a price target of $11.00.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Learn moreRetinol is widely recognized as a graceful aging powerhouse due to far-ranging benefits that include making ...

Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...

"If your skin is extremely dry and inflamed, applying a zinc oxide–based diaper rash cream can help repair your skin barrier ...

Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, ...

Journey Medical Corporation’s DERM share price has surged by 14.32%, which has investors questioning if this is right time to sell.

Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S ...